Keyphrases
Naltrexone
61%
Opiates
56%
Diabetic Rats
56%
Streptozotocin
55%
Diabetes
55%
Serum Prolactin
50%
Luteinizing Hormone
50%
Ether
50%
Prolactin
50%
Challenge Study
50%
Morphine
35%
Opioid Receptors
34%
Diabetic
28%
Blood Urea Nitrogen
18%
Nitrogen Levels
18%
Prolactin Secretion
17%
Prolactin Levels
12%
Hormone Response
12%
Presensitization
11%
System Involvement
11%
Streptozotocin-induced Diabetic Rats
11%
Normoglycemic Rats
11%
Cannulation
11%
Surgical Stress
11%
Male Rats
11%
After Surgery
11%
Normal Response
6%
Weight Loss
6%
Plasma Prolactin
6%
Severe Hyperglycemia
6%
Plasma Glucose
6%
Luteinizing Hormone Secretion
6%
System Impairments
6%
STZ-induced Diabetes
6%
Endogenous Opioid Receptor
6%
Blood Glucose
6%
Glucose-urea
6%
Hormone Levels
6%
Serum Prolactin Level
5%
Adaptation
5%
Opioid Antagonist
5%
Endogenous Opioids
5%
Receptor Blockade
5%
Restraint Stress
5%
Opioid System
5%
Animal Responses
5%
Cannula Insertion
5%
Neuroscience
Prolactin
100%
Streptozotocin
64%
Naltrexone
64%
Diabetes Mellitus
61%
Opiate
56%
Luteinizing Hormone
50%
Receptor
48%
Morphine
40%
Blood Plasma
25%
Neuroendocrine System
13%
Endorphin
13%
Narcotic Antagonist
7%
Hyperglycemia
6%
Biochemistry, Genetics and Molecular Biology
Naltrexone
50%
Streptozotocin
50%
Prolactin
50%
Luteinizing Hormone
50%
Body Weight
31%
Low Drug Dose
18%
Blood Urea Nitrogen
18%
Luteinizing Hormone Blood Level
12%
Glucose Blood Level
12%
Opioid Receptor
12%
Hormone Response
12%
Prolactin Release
6%
Endorphin
6%
Luteinizing Hormone Release
6%
Prolactin Blood Level
6%
Hyperglycemia
6%
Body Weight Loss
6%
Opiate
6%
